Neha Kaul

Dr. Neha Kaul is an Adjunct Research Fellow in the Department of Neuroscience at Monash University and a Senior Dietitian at Alfred Hospital. She specializes in nutrition therapies for neurological conditions such as epilepsy, multiple sclerosis, migraine, and traumatic brain injury. Her research focuses on diet-based treatments, particularly the ketogenic diet, and the integration of digital health solutions to improve patient care. She leads the Keto eCoach Trial, a randomized controlled trial evaluating a digital health intervention for epilepsy patients on ketogenic therapy. Dr. Kaul is also the recipient of the 2024 Jack M. Pellock Travel Award in Pediatric Excellence from the American Epilepsy Society.

She holds leadership roles including researcher co-lead of the Monash Epilepsy Consumer Advisory Panel (EpiCAP) and Ketogenic Diet Interest Group Convenor for Dietitians Australia. Her work contributes to UN Sustainable Development Goals related to good health and well-being. Dr. Kaul has led the establishment of multidisciplinary dietary therapy programs at Alfred Health, one of few global services specializing in adult neurological care.

Key projects include investigating ketogenic therapy for chronic migraine (2024), developing a salivary ketone point-of-care test (2019–2023), and exploring diet’s impact on multiple sclerosis (2020). She actively collaborates with institutions like Shenzhen Children’s Hospital and Mx3 Diagnostics.

Her awards highlight her contributions to pediatric epilepsy research. Dr. Kaul is also involved in education committees for international neurological societies and maintains leadership roles in epilepsy advocacy.